Micronesia

Reimbursed Care Access

The Federated States of Micronesia (FSM) regulates controlled substances through a coding system derived from the Trust Territory / U.S. uniform controlled-substances model. Classical psychedelics such as psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, ibogaine and many phenethylamines are explicitly listed as controlled substances in FSM law and have no authorized routine medical use outside research. Ketamine is recognized internationally as an essential anesthetic and is managed under FSM’s controlled‑substances framework; its clinical use for anesthesia and emergency medicine is provisioned under FSM law and international guidance, but specialized psychedelic indications (e.g., reimbursed ketamine therapy for depression or nationally approved esketamine programs) are not established in public national reimbursement schemes. Regulatory text: FSM controlled‑substances schedules list many classical psychedelics explicitly [https://fsmlaw.org/fsm/code/title11/T11_Ch11.htm|FSM Code – Title 11, Chapter 11] and FSM statutory text is reproduced/annotated at WIPO Lex. [https://wipolex-res.wipo.int/edocs/lexdocs/laws/en/fm/fm005en.html|WIPO Lex – FSM Controlled Substances].